BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36722130)

  • 1. cfDNA methylation in liquid biopsies as potential testicular seminoma biomarker.
    Raos D; Oršolić D; Mašić S; Tomić M; Krasić J; Tomašković I; Gabaj NN; Gelo N; Kaštelan Ž; Kuliš T; Bojanac AK; Barešić A; Ulamec M; Ježek D; Sincic N
    Epigenomics; 2022 Dec; 14(23):1493-1507. PubMed ID: 36722130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA.
    Hlady RA; Zhao X; Pan X; Yang JD; Ahmed F; Antwi SO; Giama NH; Patel T; Roberts LR; Liu C; Robertson KD
    Theranostics; 2019; 9(24):7239-7250. PubMed ID: 31695765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic analysis of cell-free DNA by fragmentomic profiling.
    Zhou Q; Kang G; Jiang P; Qiao R; Lam WKJ; Yu SCY; Ma ML; Ji L; Cheng SH; Gai W; Peng W; Shang H; Chan RWY; Chan SL; Wong GLH; Hiraki LT; Volpi S; Wong VWS; Wong J; Chiu RWK; Chan KCA; Lo YMD
    Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2209852119. PubMed ID: 36288287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNV Hotspots in Testicular Seminoma Tissue and Seminal Plasma.
    Raos D; Abramović I; Tomić M; Vrtarić A; Kuliš T; Ćorić M; Ulamec M; Katušić Bojanac A; Ježek D; Sinčić N
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detection.
    Markou Α; Londra D; Tserpeli V; Kollias Ι; Tsaroucha E; Vamvakaris I; Potaris K; Pateras I; Kotsakis Α; Georgoulias V; Lianidou Ε
    Clin Epigenetics; 2022 May; 14(1):61. PubMed ID: 35538556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
    Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
    Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal lung epithelium DNA methylation markers for detection of lung damage in liquid biopsies.
    Magenheim J; Rokach A; Peretz A; Loyfer N; Cann G; Amini H; Moradi P; Nagaraju S; Sameer W; Cohen A; Fogel O; Kuint R; Abutbul A; Abu Rmeileh A; Karameh M; Cohen Goichman P; Wald O; Korach A; Neiman D; Fox-Fisher I; Moss J; Cohen D; Piyanzin S; Ben Ami R; Quteineh A; Golomb E; Shemer R; Glaser B; Kaplan T; Fridlender ZG; Dor Y
    Eur Respir J; 2022 Nov; 60(5):. PubMed ID: 35450968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid biopsies: DNA methylation analyses in circulating cell-free DNA.
    Zeng H; He B; Yi C; Peng J
    J Genet Genomics; 2018 Apr; 45(4):185-192. PubMed ID: 29706556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of FBN1, SPG20, ITF2, RUNX3, SNCA, MLH1, and SEPT9 genes in circulating cell-free DNA as biomarkers of colorectal cancer.
    Alizadeh-Sedigh M; Fazeli MS; Mahmoodzadeh H; Sharif SB; Teimoori-Toolabi L
    Cancer Biomark; 2022; 34(2):221-250. PubMed ID: 34957998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy.
    Gai W; Sun K
    Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leveraging locus-specific epigenetic heterogeneity to improve the performance of blood-based DNA methylation biomarkers.
    Miller BF; Pisanic Ii TR; Margolin G; Petrykowska HM; Athamanolap P; Goncearenco A; Osei-Tutu A; Annunziata CM; Wang TH; Elnitski L
    Clin Epigenetics; 2020 Oct; 12(1):154. PubMed ID: 33081832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAGEC2 is a sensitive and novel marker for seminoma: a tissue microarray analysis of 325 testicular germ cell tumors.
    Bode PK; Barghorn A; Fritzsche FR; Riener MO; Kristiansen G; Knuth A; Moch H
    Mod Pathol; 2011 Jun; 24(6):829-35. PubMed ID: 21780320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation biomarkers for noninvasive detection of triple-negative breast cancer using liquid biopsy.
    Manoochehri M; Borhani N; Gerhäuser C; Assenov Y; Schönung M; Hielscher T; Christensen BC; Lee MK; Gröne HJ; Lipka DB; Brüning T; Brauch H; Ko YD; Hamann U
    Int J Cancer; 2023 Mar; 152(5):1025-1035. PubMed ID: 36305646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation biomarkers discovered
    Vrba L; Oshiro MM; Kim SS; Garland LL; Placencia C; Mahadevan D; Nelson MA; Futscher BW
    Epigenetics; 2020 Apr; 15(4):419-430. PubMed ID: 31775567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of liquid biopsy-based mutations in colorectal cancer by targeted sequencing assays.
    Szász I; Kiss T; Mokánszki A; Koroknai V; Deák J; Patel V; Jámbor K; Ádány R; Balázs M
    Mol Cell Probes; 2023 Feb; 67():101888. PubMed ID: 36513244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid biopsies based on DNA methylation as biomarkers for the detection and prognosis of lung cancer.
    Li P; Liu S; Du L; Mohseni G; Zhang Y; Wang C
    Clin Epigenetics; 2022 Sep; 14(1):118. PubMed ID: 36153611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Preanalytical and Analytical Methods on Cell-Free DNA Diagnostics.
    Krasic J; Abramovic I; Vrtaric A; Nikolac Gabaj N; Kralik-Oguic S; Katusic Bojanac A; Jezek D; Sincic N
    Front Cell Dev Biol; 2021; 9():686149. PubMed ID: 34552921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours.
    Honorio S; Agathanggelou A; Wernert N; Rothe M; Maher ER; Latif F
    Oncogene; 2003 Jan; 22(3):461-6. PubMed ID: 12545168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of methylation status using WGS data of plasma cfDNA for multi-cancer early detection (MCED).
    Cui P; Zhou X; Xu S; He W; Huang G; Xiong Y; Zhang C; Chang T; Feng M; Lai H; Pan Y
    Clin Epigenetics; 2024 Feb; 16(1):34. PubMed ID: 38414068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.